Application Accepted for Inhaled Pulmonary Fibrosis Treatment
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.
California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.